Several mechanisms can activate PI3K/AKT/mTOR signaling in melanoma, including the loss of tumor suppressor PTEN functions, mutations in AKT and PIK3CA, and compensatory signaling through growth factor receptors (19, 42, 43). This evidence concerns the gene PTEN and melanoma.